Literature DB >> 27085606

Nicotine restores functional connectivity of the ventral attention network in schizophrenia.

Jason Smucny1, Ann Olincy2, Jason R Tregellas3.   

Abstract

While previous work has suggested that nicotine may transiently improve attention deficits in schizophrenia, the neuronal mechanisms are poorly understood. This study is the first to examine the effects of nicotine on connectivity within the ventral attention network (VAN) during a selective attention task in schizophrenia. Using a crossover design, 17 nonsmoking patients with schizophrenia and 20 age/gender-matched nonsmoking healthy controls performed a go/no-go task with environmental noise distractors during application of a 7 mg nicotine or placebo patch. Psychophysiological interaction analysis was performed to analyze task-associated changes in connectivity between a ventral parietal cortex (VPC) seed and the inferior frontal gyrus (IFG), key components of the human VAN. Effects of nicotine on resting state VAN connectivity were also examined. A significant diagnosis × drug interaction was observed on task-associated connectivity between the VPC seed and the left IFG (F(1,35) = 8.03, p < 0.01). This effect was driven by decreased connectivity after placebo in patients and greater connectivity after nicotine. Resting state connectivity analysis showed a significant main effect of diagnosis between the seed and right IFG (F = 4.25, p = 0.023) due to increased connectivity in patients during placebo, but no drug × diagnosis interactions or main effects of drug. This study is the first to demonstrate that 1) the VAN is disconnected in schizophrenia during selective attention, and 2) nicotine may normalize this pathological state.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Attention; Connectivity; Nicotine; Schizophrenia; Ventral attention network; fMRI

Mesh:

Substances:

Year:  2016        PMID: 27085606      PMCID: PMC4912919          DOI: 10.1016/j.neuropharm.2016.04.015

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  61 in total

1.  A methodological note on evaluating performance in a sustained-attention-to-response task.

Authors:  Paul Seli; Tanya R Jonker; Grayden J F Solman; James Allan Cheyne; Daniel Smilek
Journal:  Behav Res Methods       Date:  2013-06

2.  Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

Authors:  A Olincy; D A Young; R Freedman
Journal:  Biol Psychiatry       Date:  1997-07-01       Impact factor: 13.382

3.  Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia.

Authors:  Jason R Tregellas; Deana B Davalos; Donald C Rojas; Merilyne C Waldo; Linzi Gibson; Korey Wylie; Yiping P Du; Robert Freedman
Journal:  Schizophr Res       Date:  2007-03-02       Impact factor: 4.939

Review 4.  Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia.

Authors:  Peter J Uhlhaas
Journal:  Curr Opin Neurobiol       Date:  2012-12-07       Impact factor: 6.627

Review 5.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

6.  The effect of distracting noise on the neuronal mechanisms of attention in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Lindsay Eichman; Donald C Rojas
Journal:  Schizophr Res       Date:  2012-10-09       Impact factor: 4.939

7.  Normalization of auditory physiology by cigarette smoking in schizophrenic patients.

Authors:  L E Adler; L D Hoffer; A Wiser; R Freedman
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

8.  The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.

Authors:  Ruth S Barr; Melissa A Culhane; Lindsay E Jubelt; Rana S Mufti; Michael A Dyer; Anthony P Weiss; Thilo Deckersbach; John F Kelly; Oliver Freudenreich; Donald C Goff; A Eden Evins
Journal:  Neuropsychopharmacology       Date:  2007-04-18       Impact factor: 7.853

9.  Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.

Authors:  Xiang Yang Zhang; Lei Liu; Shaowen Liu; Xiaohong Hong; Da Chun Chen; Mei Hong Xiu; Fu De Yang; Zhijun Zhang; Xiangrong Zhang; Therese A Kosten; Thomas R Kosten
Journal:  Am J Psychiatry       Date:  2012-09       Impact factor: 18.112

10.  Dysconnectivity in the frontoparietal attention network in schizophrenia.

Authors:  Jonathan P Roiser; Rebekah Wigton; James M Kilner; Maria A Mendez; Nicholas Hon; Karl J Friston; Eileen M Joyce
Journal:  Front Psychiatry       Date:  2013-12-24       Impact factor: 4.157

View more
  4 in total

1.  Nicotinic modulation of salience network connectivity and centrality in schizophrenia.

Authors:  Jason Smucny; Korey P Wylie; Eugene Kronberg; Kristina T Legget; Jason R Tregellas
Journal:  J Psychiatr Res       Date:  2017-02-03       Impact factor: 4.791

Review 2.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

3.  Functional connectivity when detecting rare visual targets in schizophrenia.

Authors:  Amy M Jimenez; Junghee Lee; Michael F Green; Jonathan K Wynn
Journal:  Psychiatry Res Neuroimaging       Date:  2017-01-17       Impact factor: 2.376

Review 4.  Alterations of Intrinsic Brain Connectivity Patterns in Depression and Bipolar Disorders: A Critical Assessment of Magnetoencephalography-Based Evidence.

Authors:  Golnoush Alamian; Ana-Sofía Hincapié; Etienne Combrisson; Thomas Thiery; Véronique Martel; Dmitrii Althukov; Karim Jerbi
Journal:  Front Psychiatry       Date:  2017-03-17       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.